Our mission is to find a cure for all types of blood cancer - leukemias, lymphomas, myelomas, myelodysplastic syndromes, and myeloproliferative neoplasms - and to improve the quality of life for Canadians impacted by a blood cancer.

LLSC has awarded more than $23 million in blood cancer research funding since 1995, and provides free informational, vetted multimedia resources, free programs and support, and acts as advocates for both individuals affected by a blood cancer and for the blood cancer community in Canada as a whole.